Titre :
|
Antidepressant medication use and non-Hodgkin's lymphoma risk : No association. (2004)
|
Auteurs :
|
Saira BAHL ;
Michelle COTTERCHIO ;
Neil KLAR ;
KREIGER (Nancy) : CAN. Department of Nutritional Sciences. University of Toronto. Toronto. ON. ;
Cancer Care Ontario. Division of Preventive Oncology. Toronto. ON. CAN
|
Type de document :
|
Article
|
Dans :
|
American journal of epidemiology (vol. 160, n° 6, 2004)
|
Pagination :
|
566-575
|
Langues:
|
Anglais
|
Mots-clés :
|
Antidépresseur
;
Cancer
;
Facteur risque
;
Homme
;
Facteur associé
;
Association
;
Enquête cas témoin
;
Epidémiologie
;
Médicament psychotrope
|
Résumé :
|
[BDSP. Notice produite par INIST-CNRS 6R0xhlKU. Diffusion soumise à autorisation]. Animal and human studies have suggested that antidepressant medications may be associated with several cancers. The authors evaluated the association between antidepressant medication use and the risk of non-Hodgkin's lymphoma using a Canadian population-based case-control study, the National Enhanced Cancer Surveillance Study. Non-Hodgkin's lymphoma cases (n=638) diagnosed in 1995-1996 were identified using the Ontario Cancer Registry, and controls (n=1,930) were identified from the Ontario Ministry of Finance Property Assessment Database. Antidepressant medication use was ascertained using a self-administered questionnaire. Multivariate logistic regression was used to estimate odds ratios. "Ever" use of antidepressant medications was not associated with non-Hodgkin's lymphoma risk. The odds ratio for non-Hodgkin's lymphoma with 25 or more months of tricyclic antidepressant medication use was 1.6 ; however, this was nonsignificant. Duration or history of use or individual types of antidepressant medications were not associated with non-Hodgkin's lymphoma risk. These findings do not support an increased risk of non-Hodgkin's lymphoma with antidepressant medication use.
|